Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression

Tadanori Hamano, Tania D Gendron, Ena Causevic, Shu Hui Yen, Wen Lang Lin, Ciro Isidoro, Michael Deture, Li Wen Ko

Research output: Contribution to journalArticle

161 Citations (Scopus)

Abstract

The intracellular assembly of tau aggregates is a pathological hallmark shared by Alzheimer's disease and other neurodegenerative disorders known collectively as tauopathies. To model how tau fibrillogenesis evolves in tauopathies, we previously established transfectant M1C cultures from human neuroblastoma BE(2)-M17D cells that inducibly express human tau. In the present study, these cells were used to determine the role of the autophagic-lysosomal system in the degradation and aggregation of wild-type tau. Tau induction for 5 days led to the accumulation of tau with nominal assembly of tau aggregates within cells. When the lysosomotropic agent, chloroquine (CQ), was added following the termination of tau induction, tau clearance was delayed. Decreased tau truncation and increased levels of intact tau were observed. When present during tau induction, CQ led to tau accumulation and promoted the formation of sarkosyl-insoluble aggregates containing both truncated and full-length tau. CQ treatment significantly decreased the activities of cathepsins D, B and L, and the inhibition of cathepsins B and L mimicked the effect of CQ and increased tau levels in cells. Additionally, exposure of cells to the autophagy inhibitor, 3-methyladenine, led to tau accumulation and aggregation. These results suggest that the autophagic-lysosomal system plays a role in the clearance of tau, and that dysfunction of this system results in the formation of tau oligomers and insoluble aggregates.

Original languageEnglish (US)
Pages (from-to)1119-1130
Number of pages12
JournalEuropean Journal of Neuroscience
Volume27
Issue number5
DOIs
StatePublished - Mar 2008

Fingerprint

Chloroquine
Tauopathies
Cathepsin L
Cathepsin B
Cathepsin D
Autophagy
Neuroblastoma
Neurodegenerative Diseases
Alzheimer Disease

Keywords

  • Alzheimer's disease
  • Chloroquine
  • Human neuroblastoma cell model
  • Lysosome
  • Tauopathy

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression. / Hamano, Tadanori; Gendron, Tania D; Causevic, Ena; Yen, Shu Hui; Lin, Wen Lang; Isidoro, Ciro; Deture, Michael; Ko, Li Wen.

In: European Journal of Neuroscience, Vol. 27, No. 5, 03.2008, p. 1119-1130.

Research output: Contribution to journalArticle

Hamano, Tadanori ; Gendron, Tania D ; Causevic, Ena ; Yen, Shu Hui ; Lin, Wen Lang ; Isidoro, Ciro ; Deture, Michael ; Ko, Li Wen. / Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression. In: European Journal of Neuroscience. 2008 ; Vol. 27, No. 5. pp. 1119-1130.
@article{c421b317b5f3433ab925e2958a60c387,
title = "Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression",
abstract = "The intracellular assembly of tau aggregates is a pathological hallmark shared by Alzheimer's disease and other neurodegenerative disorders known collectively as tauopathies. To model how tau fibrillogenesis evolves in tauopathies, we previously established transfectant M1C cultures from human neuroblastoma BE(2)-M17D cells that inducibly express human tau. In the present study, these cells were used to determine the role of the autophagic-lysosomal system in the degradation and aggregation of wild-type tau. Tau induction for 5 days led to the accumulation of tau with nominal assembly of tau aggregates within cells. When the lysosomotropic agent, chloroquine (CQ), was added following the termination of tau induction, tau clearance was delayed. Decreased tau truncation and increased levels of intact tau were observed. When present during tau induction, CQ led to tau accumulation and promoted the formation of sarkosyl-insoluble aggregates containing both truncated and full-length tau. CQ treatment significantly decreased the activities of cathepsins D, B and L, and the inhibition of cathepsins B and L mimicked the effect of CQ and increased tau levels in cells. Additionally, exposure of cells to the autophagy inhibitor, 3-methyladenine, led to tau accumulation and aggregation. These results suggest that the autophagic-lysosomal system plays a role in the clearance of tau, and that dysfunction of this system results in the formation of tau oligomers and insoluble aggregates.",
keywords = "Alzheimer's disease, Chloroquine, Human neuroblastoma cell model, Lysosome, Tauopathy",
author = "Tadanori Hamano and Gendron, {Tania D} and Ena Causevic and Yen, {Shu Hui} and Lin, {Wen Lang} and Ciro Isidoro and Michael Deture and Ko, {Li Wen}",
year = "2008",
month = "3",
doi = "10.1111/j.1460-9568.2008.06084.x",
language = "English (US)",
volume = "27",
pages = "1119--1130",
journal = "European Journal of Neuroscience",
issn = "0953-816X",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression

AU - Hamano, Tadanori

AU - Gendron, Tania D

AU - Causevic, Ena

AU - Yen, Shu Hui

AU - Lin, Wen Lang

AU - Isidoro, Ciro

AU - Deture, Michael

AU - Ko, Li Wen

PY - 2008/3

Y1 - 2008/3

N2 - The intracellular assembly of tau aggregates is a pathological hallmark shared by Alzheimer's disease and other neurodegenerative disorders known collectively as tauopathies. To model how tau fibrillogenesis evolves in tauopathies, we previously established transfectant M1C cultures from human neuroblastoma BE(2)-M17D cells that inducibly express human tau. In the present study, these cells were used to determine the role of the autophagic-lysosomal system in the degradation and aggregation of wild-type tau. Tau induction for 5 days led to the accumulation of tau with nominal assembly of tau aggregates within cells. When the lysosomotropic agent, chloroquine (CQ), was added following the termination of tau induction, tau clearance was delayed. Decreased tau truncation and increased levels of intact tau were observed. When present during tau induction, CQ led to tau accumulation and promoted the formation of sarkosyl-insoluble aggregates containing both truncated and full-length tau. CQ treatment significantly decreased the activities of cathepsins D, B and L, and the inhibition of cathepsins B and L mimicked the effect of CQ and increased tau levels in cells. Additionally, exposure of cells to the autophagy inhibitor, 3-methyladenine, led to tau accumulation and aggregation. These results suggest that the autophagic-lysosomal system plays a role in the clearance of tau, and that dysfunction of this system results in the formation of tau oligomers and insoluble aggregates.

AB - The intracellular assembly of tau aggregates is a pathological hallmark shared by Alzheimer's disease and other neurodegenerative disorders known collectively as tauopathies. To model how tau fibrillogenesis evolves in tauopathies, we previously established transfectant M1C cultures from human neuroblastoma BE(2)-M17D cells that inducibly express human tau. In the present study, these cells were used to determine the role of the autophagic-lysosomal system in the degradation and aggregation of wild-type tau. Tau induction for 5 days led to the accumulation of tau with nominal assembly of tau aggregates within cells. When the lysosomotropic agent, chloroquine (CQ), was added following the termination of tau induction, tau clearance was delayed. Decreased tau truncation and increased levels of intact tau were observed. When present during tau induction, CQ led to tau accumulation and promoted the formation of sarkosyl-insoluble aggregates containing both truncated and full-length tau. CQ treatment significantly decreased the activities of cathepsins D, B and L, and the inhibition of cathepsins B and L mimicked the effect of CQ and increased tau levels in cells. Additionally, exposure of cells to the autophagy inhibitor, 3-methyladenine, led to tau accumulation and aggregation. These results suggest that the autophagic-lysosomal system plays a role in the clearance of tau, and that dysfunction of this system results in the formation of tau oligomers and insoluble aggregates.

KW - Alzheimer's disease

KW - Chloroquine

KW - Human neuroblastoma cell model

KW - Lysosome

KW - Tauopathy

UR - http://www.scopus.com/inward/record.url?scp=41149085729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41149085729&partnerID=8YFLogxK

U2 - 10.1111/j.1460-9568.2008.06084.x

DO - 10.1111/j.1460-9568.2008.06084.x

M3 - Article

C2 - 18294209

AN - SCOPUS:41149085729

VL - 27

SP - 1119

EP - 1130

JO - European Journal of Neuroscience

JF - European Journal of Neuroscience

SN - 0953-816X

IS - 5

ER -